Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
01/09/1996 | US5482716 Medicaments |
01/09/1996 | CA2153208A1 Upa binding sites on domain 2+3 on upar and antibodies reactive therewith |
01/09/1996 | CA2074639C Pharmaceutical composition suitable for influencing the reticuloendothelic system and for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or accompanying diseases of tumorous origin, a process for preparing same and its use |
01/09/1996 | CA2013895C Substituted 1-¬3-(heteroarylmethoxy)phenyl|alkanols and related compounds in the treatment of asthma, arthritis and related diseases |
01/04/1996 | WO1996000218A1 Compounds for and method of inhibiting phosphodiesterase iv |
01/04/1996 | WO1996000214A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
01/04/1996 | WO1996000082A1 Medical use of bromelain |
01/04/1996 | WO1996000073A1 Treatment of optic neuritis |
01/04/1996 | WO1996000060A1 Topical compositions comprising n-acetyl-l-cysteine |
01/04/1996 | WO1995031985A3 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
01/04/1996 | CA2193725A1 Aryl derivative compounds and uses to inhibit phosphodiesterase iv acti vity |
01/04/1996 | CA2193654A1 Medical use of bromelain |
01/03/1996 | EP0690050A1 (Thia)cycloalkyl(b) indole derivatives as 5-lipoxygenase inhibitors |
01/03/1996 | EP0689538A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
01/03/1996 | EP0689449A1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine |
01/03/1996 | EP0689434A1 Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
01/03/1996 | EP0689428A1 Enhanced circulation effector composition and method |
01/03/1996 | EP0619806B1 Preparation of substituted piperidines |
01/03/1996 | EP0513104B1 USE OF AN alpha-tocoPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED |
01/03/1996 | CN1114310A 1H-indole-3-glyoxylamide spla2 inhibitors |
01/03/1996 | CN1114195A Pharmaceutical composition for treating stomaperipheral inflammation diseases |
01/03/1996 | CN1114194A Pharmaceutical composition for treating inflammatory bowel diseases |
01/02/1996 | US5481043 Phenone compounds, manufacturing method and pharmaceutical preparations containing them |
01/02/1996 | US5480983 Adenosine derivatives, preparation methods and pharmaceutical compositions containing them |
01/02/1996 | US5480901 Method for reducing unwanted cellular adhesions |
01/02/1996 | US5480873 Arthritis |
01/02/1996 | US5480796 Antibodies against the receptor protein for human B cell stimulatory factor-2 |
01/02/1996 | US5480652 Effervescent pharmaceutical composition containing ibuprofen and its method of preparation |
12/29/1995 | CA2152725A1 (thia)cycloalkyl [b] indoles; process for preparing the same and pharmaceutical compositions containing them |
12/28/1995 | WO1995035372A1 5-lipoxygenase-activating protein ii |
12/28/1995 | WO1995035308A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
12/28/1995 | WO1995035304A1 Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines |
12/28/1995 | WO1995035300A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
12/28/1995 | WO1995035284A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
12/28/1995 | WO1995035276A1 Metalloproteinase inhibitors |
12/28/1995 | WO1995035275A1 Metalloproteinase inhibitors |
12/28/1995 | WO1995035104A1 Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl)propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients |
12/28/1995 | WO1995035103A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof |
12/28/1995 | CA2193692A1 Metalloproteinase inhibitors |
12/28/1995 | CA2193691A1 Metalloproteinase inhibitors |
12/28/1995 | CA2193645A1 Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines |
12/28/1995 | CA2193644A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
12/28/1995 | CA2193396A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof |
12/27/1995 | EP0688568A1 Use of spherical activated carbon for the treatment of stoma-peripheral inflammation diseases |
12/27/1995 | EP0688567A1 Use of spherical activated carbon for the treatment of inflammatory bowel diseases |
12/27/1995 | EP0688337A1 Compositions and methods for the treatment of immunomediated inflammatory disorders |
12/27/1995 | EP0688211A1 Methods and compositions for inhibition of angiogenesis |
12/27/1995 | EP0607178A4 Methods for the selection, separation and fusion of cells. |
12/26/1995 | US5478957 Preparation of 6α, 9α-difluoro steroids |
12/26/1995 | US5478942 Cyclic urea derivatives and pharmaceutical compositions containing these compounds |
12/26/1995 | US5478941 Enantiomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl]piperazine |
12/26/1995 | US5478925 Peptides which block the binding of Tumor Necrosis Factor to its receptors |
12/26/1995 | US5478856 Styrene derivatives and salts thereof |
12/26/1995 | US5478848 Inhibition of arthritis by L-type calcium channel antagonists nimodipine, nisoldipine and nifedipine |
12/26/1995 | US5478844 Method of using aminocoumaran derivatives for treating cerebrovascular diseases |
12/26/1995 | US5478842 Antiinflammatory agents, antiallergens, drugs for treatment of diseases mediated by leukotrienes |
12/26/1995 | US5478827 Pyrazole derivatives |
12/26/1995 | US5478822 Antiallergens, antiinflammatory, cardiovascular agents |
12/26/1995 | US5478821 Method of accelerating the proliferation of emdothelial cells with inhibition of no synthases |
12/26/1995 | CA2028746C Pharmaceutical compositions and methods for treating the symptoms of overindulgence |
12/26/1995 | CA2004534C Metallo-organic compounds and uses thereof |
12/26/1995 | CA1337797C Medicated cleansing pads |
12/21/1995 | WO1995034565A1 Rapamycin amidino carbamates and pharmaceutical compositions containing them |
12/21/1995 | WO1995034563A1 Pyrazolo and pyrrolopyridines |
12/21/1995 | WO1995034561A1 Benzoylecgonine, ecgonine and ecgonidine derivatives |
12/21/1995 | WO1995034533A1 Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations |
12/21/1995 | WO1995034324A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
12/21/1995 | WO1995034312A1 Constrained peptides |
12/21/1995 | WO1995034300A1 Process for the preparation of acanthoic acid and pharmaceutical composition comprising same |
12/21/1995 | CA2192972A1 Rapamycin amidino carbamates and pharmaceutical compositions containing them |
12/21/1995 | CA2191870A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
12/21/1995 | CA2191479A1 Constrained peptides |
12/21/1995 | CA2190611A1 Covalently coupled benzoylecgonine, ecgonine and ecgonidine derivatives |
12/21/1995 | CA2169747A1 Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations |
12/20/1995 | EP0687468A2 Pharmaceutical composition for suppressing infiltration of eosinophils |
12/20/1995 | EP0687268A1 Spiroazacyclic derivatives as substance p antagonists |
12/20/1995 | EP0687265A1 Heterocyclic compounds and their preparation and use |
12/20/1995 | EP0687249A1 Balanoids |
12/20/1995 | EP0462258B1 Ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
12/20/1995 | CN1113434A Drug |
12/19/1995 | US5476866 Isoxazoles |
12/19/1995 | US5476860 Diaromatic compounds derived from a salicylic unit and their use in human and veterinary medicine and in cosmetics |
12/19/1995 | US5476851 Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinase |
12/19/1995 | CA1337782C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation |
12/19/1995 | CA1337781C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation |
12/19/1995 | CA1337767C Indolocarbazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
12/19/1995 | CA1337763C Staurosporine derivatives with substituted methylamino nitrogen |
12/14/1995 | WO1995033772A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
12/14/1995 | WO1995033770A1 Ligands for induction of antigen specific apoptosis in t cells |
12/14/1995 | WO1995033765A1 Conformationally constrained backbone cyclized peptide analog |
12/14/1995 | WO1995033763A1 Novel elastase inhibitors |
12/14/1995 | WO1995033762A1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same |
12/14/1995 | WO1995033751A1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme |
12/14/1995 | WO1995033750A1 Corticotropin releasing factor antagonists |
12/14/1995 | WO1995033744A1 Tachykinin (nk1) receptor antagonists |
12/14/1995 | WO1995033727A1 Substituted pyrazoles having corticotropin-releasing factor (crf) antagonist activity |
12/14/1995 | WO1995033712A1 Anti-inflammatory compounds |
12/14/1995 | WO1995033478A1 Acylated enol derivatives as prodrugs of elastase inhibitors |
12/14/1995 | WO1995033473A1 Extracts of stephania tetrandra for inhibition of interleukin-6 production |
12/14/1995 | WO1995033461A1 Anti-inflammatory compounds |